A neurosurgeon and a neuroscientist discover promising new ways to help people with spinal cord injuries walk again ...
More than 15 million people worldwide are living with spinal cord injury (SCI), which can affect their sensory and motor ...
23h
GlobalData on MSNLineage begins study of OPC1 delivering device for spinal cord injury treatmentFailed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...
Her injuries have left her with paralysis in her right leg, weakness in her left leg and some degree of paralysis in both ...
Jay Simpson's family and community are surrounding him in love after the little boy sustained a serious spinal surgery on Christmas Day.
Spinal cord injuries (SCIs) can temporarily or permanently disrupt ... innovative treatments to enable nervous system repair in the settings of traumatic injury and disease. In this Innovation ...
Neuvotion has received FDA 510(k) clearance for their first product, NeuStimâ„¢, a non-invasive, surgery-free wearable that ...
A new FDA-approved device is bringing hope to people who have suffered spinal injuries and helping them regain function they ...
Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury: Carlsbad, California Thursday, February 13, 2025, 14:00 Hrs [IST] Lineage Cell Therapeutic ...
Lineage Cell Therapeutics (LCTX) announced that the Company has initiated the DOSED clinical study. The DOSED study will evaluate the safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results